Antimicrobial Therapy Duration for Bloodstream Infections Caused by <i>Pseudomonas aeruginosa</i> or <i>Acinetobacter baumannii-calcoaceticus complex</i>: A Retrospective Cohort Study
Background: Ideal therapy duration for <i>Pseudomonas aeruginosa</i> or <i>Acinetobacter baumannii-calcoaceticus complex</i> (ABC) bloodstream infections (BSI) is not defined, especially in the context of carbapenem resistance. In this study, we compared short- (≤7 days) and...
Main Authors: | Rodrigo Douglas Rodrigues, Rebeca Carvalho Lacerda Garcia, Gabriel Almeida Bittencourt, Vicente Bouchet Waichel, Ester Carvalho Lacerda Garcia, Maria Helena Rigatto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/538 |
Similar Items
-
Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023-08-01) -
Profiling Antibiotic Resistance in <i>Acinetobacter calcoaceticus</i>
by: Janiece S. Glover, et al.
Published: (2022-07-01) -
Molecular Epidemiology of Clinical Carbapenem-Resistant <i>Acinetobacter baumannii-calcoaceticus</i> complex Isolates in Tertiary Care Hospitals in Java and Sulawesi Islands, Indonesia
by: Heriyannis Homenta, et al.
Published: (2022-09-01) -
A bioinformatic approach to identify confirmed and probable CRISPR–Cas systems in the Acinetobacter calcoaceticus–Acinetobacter baumannii complex genomes
by: Jetsi Mancilla-Rojano, et al.
Published: (2024-04-01) -
<i>Acinetobacter baumannii</i> Bloodstream Infections: A Nationwide Study in Israel
by: Amir Nutman, et al.
Published: (2023-08-01)